Research effects of Testosterone undecanoate administration on metabolic and hormonal parameters at men with an obesity and a chronic heart failure

Research effects of Testosterone undecanoate administration on metabolic and hormonal parameters at men with an obesity and a chronic heart failure

Show other versions (1)

<p align="LEFT">The ATP III criteria of the metabolic syndrome (MS) comprise impaired fasting glucose (> 5.6 nmol/L), waist circumference > 102 cm, hypertension (> 130/85 mm Hg), high triglycerides (> 1.7 nmol/L) and low HDL-cholesterol (≤<em><spa...

Full description

Bibliographic Details
Main Authors:	N. P. Goncharov, G. V. Katsya, L. M. Gaivoronskaya, V. I. Zoloedov, V. M. Uskov
Format:	Article
Language:	Russian
Published:	ABV-press 2014-11-01
Series:	Andrologiâ i Genitalʹnaâ Hirurgiâ
Subjects:	testosterone chronic heart failure obesity treatment
Online Access:	http://agx.abvpress.ru/index.php/jour/article/view/26

Similar Items

Research effects of Testosterone undecanoate administration on metabolic and hormonal parameters at men with an obesity and a chronic heart failure
by: N. P. Goncharov, et al.
Published: (2014-11-01)

Central hemodynamics and androgen status in men with coronary heart disease, and androgen deficiency in its correction of prolonged administration of testosterone
by: L. M. Gaivoronskaya, et al.
Published: (2014-11-01)

Central hemodynamics and androgen status in men with coronary heart disease, and androgen deficiency in its correction of prolonged administration of testosterone
by: L. M. Gaivoronskaya, et al.
Published: (2014-11-01)

Effect of a Combination of Omega-3 and Oral Testosterone Undecanoate On Serum Testosterone Levels in Patients with Testosterone Deficiency
by: Min Gu Park, et al.
Published: (2020-06-01)

Testosterone undecanoate effects on cardiovascular risk factors in men with metabolic syndrome
by: A. L. Vertkin, et al.
Published: (2008-10-01)

Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men
by: Nandini Shankara Narayana, et al.
Published: (2021-07-01)

Pharmacokinetics and Acceptability of Subcutaneous Injection of Testosterone Undecanoate
by: Conway, A, et al.
Published: (2019)

UGT2B17 genotype and the pharmacokinetic serum profile of Testosterone during substitution therapy with Testosterone Undecanoate. A retrospective experience from 207 men with hypogonadism.
by: Anne Kirstine eBang, et al.
Published: (2013-07-01)

Pharmacokinetics and Acceptability of Subcutaneous Injection of Testosterone Undecanoate
by: Conway, A., et al.
Published: (2019)

Effect of a Combination of Dutasteride and Parenteral Testosterone Undecanoate on Testosterone Deficiency Symptoms and Prostate in Patients with Testosterone Efficiency and Benign Prostatic Hyperplasia
by: Min Gu Park, et al.
Published: (2020-06-01)

Strawberry Decreases Intraluminal and Intestinal Wall Hydrolysis of Testosterone Undecanoate
by: Atheer Zgair, et al.
Published: (2021-01-01)

Predicting Intestinal and Hepatic First-Pass Metabolism of Orally Administered Testosterone Undecanoate
by: Atheer Zgair, et al.
Published: (2020-10-01)

Occurrence of Pulmonary Oil Microembolism After Testosterone Undecanoate Injection: A Postmarketing Safety Analysis
by: Alexander W. Pastuszak, MD, PhD, et al.
Published: (2020-06-01)

Suppression of spermatogenesis by testosterone undecanoate-loaded injectable in situ-forming implants in adult male rats
by: Xiao-Wei Zhang, et al.
Published: (2016-01-01)

Combined effects of growth hormone and testosterone replacement treatment in heart failure
by: Andrea Salzano, et al.
Published: (2019-12-01)

Cognitive effects of testosterone and finasteride administration in older hypogonadal men
by: Borst SE, et al.
Published: (2014-08-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Published: (2013-03-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Published: (2012-12-01)

Low testosterone concentrations and prediction of future heart failure in men and in women: evidence from the large FINRISK97 study
by: Sarina Schäfer, et al.
Published: (2021-08-01)

Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study
by: Yin-Wei Chen, et al.
Published: (2019-01-01)

Serum Testosterone and Cortisol Concentrations After Single-Dose Administration of 100-Mg Transdermal Testosterone in Healthy Men
by: Andrei A. Puiu, et al.
Published: (2019-11-01)

Importance of Visceral Obesity and Testosterone Deficiency in the formation of metabolic disorders in men
by: Z. R. Gusova, et al.
Published: (2019-09-01)

Obstructive Sleep Apnea Is Associated With Low Testosterone Levels in Severely Obese Men
by: Milina Tančić-Gajić, et al.
Published: (2021-07-01)

Effect of Testosterone Replacement Therapy on Cognitive Performance and Depression in Men with Testosterone Deficiency Syndrome
by: Hyun Jin Jung, et al.
Published: (2016-12-01)

Effects of Five-Year Treatment with Testosterone Undecanoate on Metabolic and Hormonal Parameters in Ageing Men with Metabolic Syndrome
by: Davide Francomano, et al.
Published: (2014-01-01)

CLINICAL EFFECT OF TESTOSTERONE IN MEN WITH STABLE ANGINA
by: A. Ya. Kravchenko, et al.
Published: (2016-01-01)

The influence of testosterone on the quality and bone mineral density in men
by: V.V. Povoroznyuk, et al.
Published: (2018-03-01)

Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate‐Specific Antigen
by: Alexander W. Pastuszak, MD, PhD, et al.
Published: (2015-09-01)

Free testosterone and cardiometabolic parameters in men: comparison of algorithms
by: Stine A Holmboe, et al.
Published: (2021-03-01)

Sex, Energy, Well-Being and Low Testosterone: An Exploratory Survey of U.S. Men’s Experiences on Prescription Testosterone
by: Alex A. Straftis, et al.
Published: (2019-09-01)

Effects of administering testosterone undecanoate in rats subjected to physical exercise: effects on the estrous cycle, motor behavior and morphology of the liver and kidney
by: Moisés Tolentino Bento-Silva, et al.
Published: (2010-03-01)

Risks of testosterone replacement therapy in men
by: E Charles Osterberg, et al.
Published: (2014-01-01)

Normal Testosterone but Higher Luteinizing Hormone Plasma Levels in Men With Hypersexual Disorder
by: Andreas Chatzittofis, MD, PhD, et al.
Published: (2020-06-01)

Testosterone profile in older men with Alzheimer's disease
by: Cristiana Roscito Arenella Dusi, et al.

Testosterone levels in men with chronic migraine
by: Lisa B.E. Shields, et al.
Published: (2019-06-01)

The relationship between serum hormone levels (follicle-stimulating hormone, luteinizing hormone, total testosterone) and semen parameters
by: Mehmet Zeynel Keskin, et al.
Published: (2015-09-01)

Testosterone treatment in chronic heart failure. Review of literature and future perspectives
by: Roberta D'Assante, et al.
Published: (2018-09-01)

The Relationship between Selected Bioelements and Depressiveness Associated with Testosterone Deficiency Syndrome in Aging Men
by: Iwona Rotter, et al.
Published: (2020-03-01)

Urolithiasis is associated with low serum testosterone levels in men
by: Alper Otunctemur, et al.
Published: (2015-03-01)

Testosterone and androstanediol glucuronide among men in NHANES III
by: Chuan Wei Duan, et al.
Published: (2018-03-01)

Cannot write session to /tmp/vufind_sessions/sess_gph8ro5vd975nkccrgm8n813n1